Suppr超能文献

淋巴结中的CXCL12+成纤维细胞网状细胞通过调节T细胞介导的同种异体免疫促进免疫耐受。

CXCL12+ fibroblastic reticular cells in lymph nodes facilitate immune tolerance by regulating T cell-mediated alloimmunity.

作者信息

Yamamura Yuta, Sabiu Gianmarco, Zhao Jing, Jung Sungwook, Seelam Andy J, Li Xiaofei, Song Yang, Shirkey Marina W, Li Lushen, Piao Wenji, Wu Long, Zhang Tianshu, Ahn Soyeon, Kim Pilhan, Kasinath Vivek, Azzi Jamil R, Bromberg Jonathan S, Abdi Reza

机构信息

Transplantation Research Center and.

Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

J Clin Invest. 2025 May 1;135(9). doi: 10.1172/JCI182709.

Abstract

Fibroblastic reticular cells (FRCs) are the master regulators of the lymph node (LN) microenvironment. However, the role of specific FRC subsets in controlling alloimmune responses remains to be studied. Single-cell RNA sequencing (scRNA-Seq) of naive and draining LNs (DLNs) of heart-transplanted mice and human LNs revealed a specific subset of CXCL12hi FRCs that expressed high levels of lymphotoxin-β receptor (LTβR) and are enriched in the expression of immunoregulatory genes. CXCL12hi FRCs had high expression of CCL19, CCL21, indoleamine 2,3-dioxygenase (IDO), IL-10, and TGF-β1. Adoptive transfer of ex vivo-expanded FRCs resulted in their homing to LNs and induced immunosuppressive environments in DLNs to promote heart allograft acceptance. Genetic deletion of LTβR and Cxcl12 in FRCs increased alloreactivity, abrogating the effect of costimulatory blockade in prolonging heart allograft survival. As compared with WT recipients, CXCL12+ FRC-deficient recipients exhibited increased differentiation of CD4+ T cells into Th1 cells. Nano delivery of CXCL12 to DLNs improved allograft survival in heart-transplanted mice. Our study highlights the importance of DLN CXCL12hi FRCs in promoting transplant tolerance.

摘要

成纤维网状细胞(FRCs)是淋巴结(LN)微环境的主要调节因子。然而,特定FRC亚群在控制同种异体免疫反应中的作用仍有待研究。对心脏移植小鼠的未致敏淋巴结(LN)和引流淋巴结(DLN)以及人类淋巴结进行单细胞RNA测序(scRNA-Seq),发现了一个特定的CXCL12高表达FRC亚群,该亚群表达高水平的淋巴毒素-β受体(LTβR),且免疫调节基因表达丰富。CXCL12高表达FRCs高表达CCL19、CCL21、吲哚胺2,3-双加氧酶(IDO)、IL-10和TGF-β1。过继转移体外扩增的FRCs导致它们归巢至淋巴结,并在引流淋巴结中诱导免疫抑制环境,以促进心脏同种异体移植的接受。FRCs中LTβR和Cxcl12的基因缺失增加了同种异体反应性,消除了共刺激阻断在延长心脏同种异体移植存活时间方面的作用。与野生型受体相比,CXCL12 + FRC缺陷型受体的CD4 + T细胞向Th1细胞的分化增加。将CXCL12纳米递送至引流淋巴结可提高心脏移植小鼠的同种异体移植存活率。我们的研究强调了引流淋巴结CXCL12高表达FRCs在促进移植耐受中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0f4/12043101/a791d0e54999/jci-135-182709-g131.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验